FILTER

Refine your search with the following facets to narrow down your results.

25 Current news of Biotechnology and Biological Sciences Research Council

Future of regenerative medicine looks bright with new funding boost

04-Apr-2017 - The UK Regenerative Medicine Platform (UKRMP), is to receive a further multimillion funding commitment to help realise the goal of accelerating scientific discoveries in regenerative therapies to clinical application. The Platform is a joint initiative between the Medical Research Council (MRC), ...

bioeconomy bioengineering biomaterials +16

Bees research shows not all neonicotinoids are the same

03-May-2016 - The group of chemical insecticides known as neonicotinoids have been identified as presenting a serious risk to bee populations, leading to bans on their use. But at least one may be unfairly named among the offenders when it comes to risks to bumblebees, according to new research led by the ...

bees food security imidacloprid +5

Fatty acids from GM oilseed crops could replace fish oil

26-Jan-2016 - Oil from genetically modified (GM) oilseed crops could replace fish oil as a primary source of the beneficial Omega 3 fatty acid EPA – according to new research from the University of East Anglia in collaboration with Rothamsted Research and the University of Stirling. BBSRC-funded researchers at ...

Camelina sativa genetic modification nutrition +1

How DNA is ‘edited’ to correct genetic diseases

28-May-2014 - An international team of scientists has made a major step forward in our understanding of how enzymes ‘edit’ genes, paving the way for correcting genetic diseases in patients. Researchers at the Universities of Bristol, Münster and the Lithuanian Institute of Biotechnology have observed the ...

CRISPR/Cas9 enzymes genetics +1

'Trojan Horse' particle sneaks chemotherapy in to kill ovarian cancer cells

14-Sep-2011 - A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune system works. The drug, delivered in this way, reduced ovarian cancer tumours in an animal model by 65 times more than using the ...

chemotherapy oncology ovarian cancer

Immune system assassin's tricks visualised for the first time

02-Nov-2010 - Scientists from the UK and Australia have seen the human immune system's assassin – a protein called perforin – in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they ...

anthrax autoimmune diseases bacteria +15

A new generation of biological scaffolds

16-Jul-2010 - Professor John Fisher from The University of Leeds has spoken at the UK National Stem Cell Network Annual Science Meeting in Nottingham about his team's research into how biological scaffolding will pave the way for off-the-shelf tissue transplants. Professor Fisher and his colleague Professor ...

longevity services stem cells +3

Mouse stem cell study offers new insights into body fat distribution

13-Jul-2010 - New research presented at the UK National Stem Cell Network Annual Science Meeting in Nottingham shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells – subcutaneous ...

biology cardiovascular diseases diseases +8

Designer nano luggage to carry drugs to diseased cells

11-Mar-2010 - For the first time, scientists have succeeded in growing empty particles derived from a plant virus and have made them carry useful chemicals. The external surface of these nano containers could be decorated with molecules that guide them to where they are needed in the body, before the chemical ...

chemicals containers integrins +1

Sarum Biosciences signs licence agreement with PBL for Clostridium difficile bacteriophage endolysin technology.

26-Jan-2010 - Sarum Biosciences Limited and PBL announced the signing of an exclusive worldwide licence agreement which enables Sarum to develop and exploit therapeutic and diagnostic applications of a bacteriophage endolysin protein for the treatment and detection of Clostridium difficile, a serious ...

antibiotics bacteria Clostridium difficile +5